Flow cytometry-assisted analysis of phenotypic maturation markers on an immortalized dendritic cell line

Ginevra Campia,Manuel Beltrán-Visiedo,Ruth Soler-Agesta,Ai Sato,Norma Bloy,Liwei Zhao,Peng Liu,Oliver Kepp,Guido Kroemer,Lorenzo Galluzzi,Claudia Galassi
DOI: https://doi.org/10.1016/bs.mcb.2024.05.008
Abstract:Dendritic cells (DCs), and especially so conventional type I DCs (cDC1s), are fundamental regulators of anticancer immunity, largely reflecting their superior ability to engulf tumor-derived material and process it for cross-presentation on MHC Class I molecules to CD8+ cytotoxic T lymphocytes (CTLs). Thus, investigating key DC functions including (but not limited to) phagocytic capacity, expression of CTL-activating ligands on the cell surface, and cross-presentation efficacy is an important component of multiple immuno-oncology studies. Unfortunately, DCs are terminally differentiated cells, implying that they cannot be propagated indefinitely in vitro and hence must be generated ad hoc from circulating or bone marrow-derived precursors, which presents several limitations. Here, we propose a simple, cytofluorometric method to quantify phenotypic activation markers including CD80, CD86 and MHC class II molecules on the surface of a conditionally immortalized immature DC line that can be indefinitely propagated in vitro but also driven into maturation at will with a simple change in culture conditions. Upon appropriate scaling and automatization, this approach is compatible with high-throughput screening programs for the discovery of novel DC activators that do not suffer from batch variability and other limitations associated with the generation of fresh DCs.
What problem does this paper attempt to address?